Health
Designed antiviral proteins inhibit SARS-CoV-2 in the lab: Computer design of synthetic proteins is creating potent, stable antivirals that block infection at least as well as monoclonal antibodies – Science Daily
Computer-designed miniproteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19. The lead antiviral candidate rivals the best-known SARS-CoV-2 monoclonal antibodies in its protective actions. The synth…
Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19.The findings are reported today, Sept. 9, in Science
In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions. LCB1 is currently being evaluated in rodents.
Coronaviruses are studded with so-called Spike proteins. These latch onto human cells to enable the virus to bre…
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General18 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News23 hours agoCat-Sitting Leads to Chaos for Austin Butler in the Trailer for Darren Aronofsky’s New Crime-Thriller ‘Caught Stealing’
-
Noosa News22 hours agoIs Auckland New Zealand’s New Cultural Capital?